Benitec Biopharma Ltd ADR (BNTC) — Capital Reinvestment Ratio
Benitec Biopharma Ltd ADR (BNTC) has a Capital Reinvestment Ratio of 0.00x as of September 2018, meaning it reinvests 0% of its operating cash flow ($5.87 Million) in capital expenditures ($26.00K). See Benitec Biopharma Ltd ADR (BNTC) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Benitec Biopharma Ltd ADR Capital Reinvestment Ratio (2019–2019)
This chart tracks Benitec Biopharma Ltd ADR's Capital Reinvestment Ratio across 1 annual periods. Check Benitec Biopharma Ltd ADR (BNTC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR (2019–2019)
Year-by-year Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR from 2019 to 2019. For live market cap and broader valuation context, see Benitec Biopharma Ltd ADR (BNTC) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.08x | $4.79 Million | $403.40K | — |